{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:22:10Z","timestamp":1792167730725,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Medical & Health Technology Program of Zhejiang Province","award":["2016KYA072"],"award-info":[{"award-number":["2016KYA072"]}]},{"name":"the Medical & Health Technology Program of Zhejiang Province","award":["2018KY652"],"award-info":[{"award-number":["2018KY652"]}]},{"name":"Hangzhou Xiaoshan District Social Development Major Science and Technology Project","award":["No.2017201"],"award-info":[{"award-number":["No.2017201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>There has been little published data on estimates of HBV and\/or HCV coinfection in HIV-positive patients in China or an understanding of how this coinfection varies with different factors. Therefore, this study aimed to determine, through a systematic review and meta-analysis, the prevalence of HBV and\/or HCV in HIV-positive patients in China and explore variations in prevalence.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The Medicine, Web of Science, Chinese Web of Knowledge, and Wanfang databases were searched using a search strategy combining key words and related disease-specific subject terms to identify relevant cohort or cross-sectional studies published up to April 2019. Included articles were assessed for quality. Pooled prevalence and 95% confidence intervals (CIs) were calculated according to study region and other specific characteristics.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Our searches identified 7843 records, but only 66 studies were included in our meta-analysis. The pooled HBsAg prevalence in HIV-positive patients was 13.7% (95% CI 12.3\u201315.3%), with variations found in terms of age and geographic region. The meta-HCV prevalence was 24.7% (95% CI 19.3\u201330.5%), which varied over the study period and age. The pooled HBV-HCV coinfection prevalence was 3.5% (95% CI 2.4\u20134.8%), with variations found in terms of age and geographic region.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Given the high burden of HBV and HCV coinfections in HIV-positive patients, the incorporation of comprehensive screening, treatment, prevention, and vaccination programs into general HIV management in China is imperative.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12985-020-01404-z","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T12:03:37Z","timestamp":1598270617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Hepatitis B and hepatitis C prevalence among people living with HIV\/AIDS in China: a systematic review and Meta-analysis"],"prefix":"10.1186","volume":"17","author":[{"given":"Songxia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1240-8612","authenticated-orcid":false,"given":"Min","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","volume":"368","author":"V Simon","year":"2006","unstructured":"Simon V, Ho DD, Abdool Karim Q. HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368:489\u2013504.","journal-title":"Lancet"},{"key":"1404_CR2","first-page":"69","volume":"22","author":"N Ncaids","year":"2016","unstructured":"Ncaids N. Update on the AIDS\/STD epidemic in China and main response in control and prevention in December, 2015. Chin J AIDS STD. 2016;22:69.","journal-title":"Chin J AIDS STD"},{"key":"1404_CR3","first-page":"677","volume":"23","author":"Prevention CCfDCa","year":"2017","unstructured":"Prevention CCfDCa. Update on the AIDS\/STD epidemic in China in the second quarter of 2017. Chinese J AIDS STD. 2017;23:677.","journal-title":"Chinese J AIDS STD"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","volume":"3","author":"D Razavi-Shearer","year":"2018","unstructured":"Razavi-Shearer D, Gamkrelidze I, Nguyen MH, Chen D-S, Van Damme P, Abbas Z, Abdulla M, Abou Rached A, Adda D, Aho I, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383\u2013403.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1404_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/S0140-6736(18)30499-9","volume":"391","author":"S Chen","year":"2018","unstructured":"Chen S, Li J, Wang D, Fung H, Wong L-Y, Zhao L. The hepatitis B epidemic in China should receive more attention. Lancet. 2018;391:1572.","journal-title":"Lancet"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","volume":"2","author":"S Blach","year":"2017","unstructured":"Blach S, Zeuzem S, Manns M, Altraif I, Duberg A-S, Muljono DH, Waked I, Alavian SM, Lee M-H, Negro F, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2:161\u201376.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3748\/wjg.v19.i10.1602","volume":"19","author":"NG Ladep","year":"2013","unstructured":"Ladep NG, Agaba PA, Agbaji O, Muazu A, Ugoagwu P, Imade G, Cooke G, McCormack S, Taylor-Robinson SD, Idoko J, Kanki P. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort. World J Gastroenterol. 2013;19:1602\u201310.","journal-title":"World J Gastroenterol"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1586\/17474124.2014.876357","volume":"8","author":"W Kang","year":"2014","unstructured":"Kang W, Tong HI, Sun Y, Lu Y. Hepatitis C virus infection in patients with HIV-1: epidemiology, natural history and management. Expert Rev Gastroenterol Hepatol. 2014;8:247\u201366.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS. 2017;31:2035\u201352.","journal-title":"AIDS"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/0956462416632428","volume":"28","author":"M Farahani","year":"2017","unstructured":"Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28:636\u201350.","journal-title":"Int J STD AIDS"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Munoz A, Thomas DL, Multicenter ACS. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter cohort study (MACS). Lancet. 2002;360:1921\u20136.","journal-title":"Lancet"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"20659","DOI":"10.7448\/IAS.19.1.20659","volume":"19","author":"J Xie","year":"2016","unstructured":"Xie J, Han Y, Qiu Z, Li Y, Li Y, Song X, Wang H, Thio CL, Li T. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study. J Int AIDS Soc. 2016;19:20659.","journal-title":"J Int AIDS Soc"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s00705-013-1681-z","volume":"158","author":"X Chen","year":"2013","unstructured":"Chen X, He J-M, Ding L-S, Zhang G-Q, Zou X-B, Zheng J. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Arch Virol. 2013;158:1889\u201394.","journal-title":"Arch Virol"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/1479-5876-12-164","volume":"12","author":"Y Liu","year":"2014","unstructured":"Liu Y, Zeng P, Wang J, Liu G, Xu M, Ke L, He M, Liu Z. Hepatitis B virus infection in a cohort of HIV infected blood donors and AIDS patients in Sichuan, China. J Translat Med. 2014;12:164.","journal-title":"J Translat Med"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/01.aids.0000233577.33973.fa","volume":"20","author":"H-Z Qian","year":"2006","unstructured":"Qian H-Z, Vermund SH, Kaslow RA, Coffey CS, Chamot E, Yang Z, Qiao X, Zhang Y, Shi X, Jiang Y. Co-infection with HIV and hepatitis C virus in former plasma\/blood donors: challenge for patient care in rural China. AIDS (London, England). 2006;20:1429.","journal-title":"AIDS (London, England)"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1073\/pnas.1321748111","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, Ren Y, Wang J, Dong Y, Bao M, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A. 2014;111:769\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1468-1293.2012.01048.x","volume":"14","author":"Y Shen","year":"2013","unstructured":"Shen Y, Wang Z, Qi T, Jiang X, Song W, Tang Y, Wang J, Liu L, Zhang R, Zheng Y. Serological survey of viral hepatitis markers among newly diagnosed patients with HIV\/AIDS in C hina. HIV Med. 2013;14:167\u201375.","journal-title":"HIV Med"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1017\/S0950268810001597","volume":"139","author":"Y Yan","year":"2011","unstructured":"Yan Y, Gao Y, Sun X, Wang W, Huang X, Zhang T, Li M, Zang C, Li Z, Wu H. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect. 2011;139:354\u201360.","journal-title":"Epidemiol Infect"},{"key":"1404_CR19","first-page":"250","volume":"1999","author":"D Moher","year":"1996","unstructured":"Moher D, Altman DG, JJ T. PRISMA (Preferred Reporting items for systematic reviews and Meta-Analyses). GfRHRAUsM. 1996;1999:250.","journal-title":"GfRHRAUsM"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc. 2015;13:147\u201353.","journal-title":"Int J Evid Based Healthc"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/S2352-3018(17)30005-X","volume":"4","author":"Z-D Wang","year":"2017","unstructured":"Wang Z-D, Wang S-C, Liu H-H, Ma H-Y, Li Z-Y, Wei F, Zhu X-Q, Liu Q. Prevalence and burden of toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV. 2017;4:e177\u201388.","journal-title":"Lancet HIV"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974\u20138.","journal-title":"J Epidemiol Community Health"},{"key":"1404_CR24","doi-asserted-by":"crossref","unstructured":"Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607\u201311.","DOI":"10.1214\/aoms\/1177729756"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"d549","DOI":"10.1136\/bmj.d549","volume":"342","author":"RD Riley","year":"2011","unstructured":"Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.","journal-title":"BMJ"},{"key":"1404_CR27","first-page":"15","volume":"2","author":"YP Yan","year":"2014","unstructured":"Yan YP, Su HX, Ji ZH, Shao ZJ, Pu ZS. Epidemiology of hepatitis B virus infection in China: current status and challenges. J Clin Transl Hepatol. 2014;2:15\u201322.","journal-title":"J Clin Transl Hepatol"},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1468-1293.2008.00599.x","volume":"9","author":"M Landes","year":"2008","unstructured":"Landes M, Newell ML, Barlow P, Fiore S, Malyuta R, Martinelli P, Posokhova S, Savasi V, Semenenko I, Stelmah A, et al. Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe. HIV Med. 2008;9:526\u201334.","journal-title":"HIV Med"},{"key":"1404_CR29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s11136-012-0283-7","volume":"22","author":"J Gillis","year":"2013","unstructured":"Gillis J, Cooper C, Rourke S, Rueda S, O'Brien K, Collins E, Rachlis A, Hart TA, Raboud J, Group OCS. Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals. Qual Life Res. 2013;22:1525\u201335.","journal-title":"Qual Life Res"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"17360","DOI":"10.3748\/wjg.v20.i46.17360","volume":"20","author":"BC Phung","year":"2014","unstructured":"Phung BC, Sogni P, Launay O. Hepatitis B and human immunodeficiency virus co-infection. World J Gastroenterol. 2014;20:17360\u20137.","journal-title":"World J Gastroenterol"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2334-12-130","volume":"12","author":"X Zhuang","year":"2012","unstructured":"Zhuang X, Liang Y, Chow EP, Wang Y, Wilson DP, Zhang L. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012;12:130.","journal-title":"BMC Infect Dis"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/cid\/cis694","volume":"55","author":"G Wandeler","year":"2012","unstructured":"Wandeler G, Gsponer T, Bregenzer A, Gunthard HF, Clerc O, Calmy A, Stockle M, Bernasconi E, Furrer H, Rauch A, Swiss HIVCS. Hepatitis C virus infections in the Swiss HIV cohort study: a rapidly evolving epidemic. Clin Infect Dis. 2012;55:1408\u201316.","journal-title":"Clin Infect Dis"},{"key":"1404_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1056\/NEJMoa1501315","volume":"373","author":"S Naggie","year":"2015","unstructured":"Naggie S, Cooper C, Saag M, Workowski K, Ruane P, Towner WJ, Marks K, Luetkemeyer A, Baden RP, Sax PE, et al. Ledipasvir and Sofosbuvir for HCV in patients Coinfected with HIV-1. N Engl J Med. 2015;373:705\u201313.","journal-title":"N Engl J Med"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/hep.26431","volume":"58","author":"NK Martin","year":"2013","unstructured":"Martin NK, Vickerman P, Grebely J, Hellard M, Hutchinson SJ, Lima VD, Foster GR, Dillon JF, Goldberg DJ, Dore GJ, Hickman M. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58:1598\u2013609.","journal-title":"Hepatology"},{"key":"1404_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1473-3099(07)70135-4","volume":"7","author":"CJ Hoffmann","year":"2007","unstructured":"Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7:402\u20139.","journal-title":"Lancet Infect Dis"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","volume":"14","author":"F Zhang","year":"2014","unstructured":"Zhang F, Zhu H, Wu Y, Dou Z, Zhang Y, Kleinman N, Bulterys M, Wu Z, Ma Y, Zhao D, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010\u201312: a retrospective observational cohort study. Lancet Infect Dis. 2014;14:1065\u201372.","journal-title":"Lancet Infect Dis"},{"key":"1404_CR37","first-page":"950","volume":"138","author":"N Chandra","year":"2013","unstructured":"Chandra N, Joshi N, Raju YS, Kumar A, Teja VD. Hepatitis B and\/or C co-infection in HIV infected patients: a study in a tertiary care Centre from South India. Indian J Med Res. 2013;138:950\u20134.","journal-title":"Indian J Med Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01404-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-020-01404-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-020-01404-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:18:30Z","timestamp":1629764310000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-020-01404-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1186\/s12985-020-01404-z","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"18 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}